SEARCH

SEARCH BY CITATION

References

  • Aklillu, E., Leong, C., Loebstein, R., Halkin, H. & Gak, E. (2008) VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals. Blood, 111, 39033904.
  • Bodin, L., Verstuyft, C., Tregouet, D.A., Robert, A., Dubert, L., Funck-Brentano, C., Jaillon, P., Beaune, P., Laurent-Puig, P., Becquemont, L. & Loriot, M.A. (2005a) Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity. Blood, 106, 135140.
  • Bodin, L., Horellou, M.H., Flaujac, C., Loriot, M.A. & Samama, M.M. (2005b) A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance. Journal of Thrombosis and Haemostasis, 3, 15331535.
  • Gan, G.G., Teh, A., Goh, K.Y., Chong, H.T. & Pang, K.W. (2003) Racial background is a determinant factor in the maintenance dosage of warfarin. International Journal of Hematology, 78, 8486.
  • Harrington, D.J., Underwood, S., Morse, C., Shearer, M.J., Tuddenham, E.G. & Mumford, A.D. (2005) Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1. Thrombosis and Haemostasis, 93, 2326.
  • Li, T., Chang, C.Y., Jin, D.Y., Lin, P.J., Khvorova, A. & Stafford, D.W. (2004) Identification of the gene for vitamin K epoxide reductase. Nature, 427, 541544.
  • Osman, A., Enström, C., Arbring, K., Söderkvist, P. & Lindahl, T.L. (2006) Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records. Journal of Thrombosis and Haemostasis, 4, 17231729.
  • Rieder, M.J., Reiner, A.P., Gage, B.F., Nickerson, D.A., Eby, C.S., McLeod, H.L., Blough, D.K., Thummel, K.E., Veenstra, D.L. & Rettie, A.E. (2005) Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. New England Journal of Medicine, 2, 352.
  • Rost, S., Fregin, A., Ivaskevicius, V., Conzelmann, E., Hortnagel, K., Pelz, H.J., Lappegard, K., Seifried, E., Scharrer, I., Tuddenham, E.G., Muller, C.R., Strom, T.M. & Oldenburg, J. (2004) Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature, 427, 537541.
  • Wilms, E.B., Touw, D.J., Conemans, J.M., Veldkamp, R. & Hermans, M. (2008) A new VKORC1 allelic variant (p.Trp59Arg) in a patient with partial resistance to acenocoumarol and phenprocoumon. Journal of Thrombosis and Haemostasis, 6, 12241226.
  • Yin, T. & Miyata, T. (2007) Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 – Rationale and perspectives. Thrombosis Research, 120, 110.